PHIO FY 2021 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$9M

Operating Income

-$14M

Net Income

-$13M

EPS (Diluted)

$-111.32

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$480,000

Balance Sheet

Total Assets

$25M

Total Liabilities

$3M

Stockholders' Equity

$22M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$9M	-$4M	-139.1%
Operating Income	-$14M	-$9M	-53.7%
Net Income	-$13M	-$9M	-51.1%